SIS
PCRX icon

Sound Income Strategies’s Pacira BioSciences PCRX Stock Holding History

Sound Income Strategies’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-240
Closed -$5.47K – 1828
2026
Q1 		$5.47K Buy
240
+157
+189% +$3.49K ﹤0.01% 1784
2025
Q4 		$1.59K Buy
+83
New +$1.97K ﹤0.01% 2193

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sound Income Strategies's PCRX Position: Q2 2026 in Review

Sound Income Strategies sold out of Pacira BioSciences (PCRX) in Q2 2026, closing a stake of 240 shares — an estimated $5.47K sold.

Sound Income Strategies first reported a position in PCRX in Q4 2025 and held it in 2 quarters. The position peaked at $5.47K in Q1 2026. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Sound Income Strategies reported no remaining Pacira BioSciences position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 240 Pacira BioSciences shares in Q2 2026, an estimated $5.47K.
  • Sound Income Strategies first reported a position in Pacira BioSciences in Q4 2025 and held it in 2 quarters.
  • Sound Income Strategies's Pacira BioSciences position peaked at $5.47K in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.